4.6 Article

Hydroxyacetone derived N4-methyl substituted thiosemicarbazone: Syntheses, crystal structures and spectroscopic characterization of later first-row transition metal complexes

Journal

JOURNAL OF MOLECULAR STRUCTURE
Volume 1224, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.molstruc.2020.129055

Keywords

Thiosemicarbazones; Transition metal complexes; Crystal structure; Antitubercular activity

Funding

  1. UGC-New Delhi [37-246/2009(SR), 101864]

Ask authors/readers for more resources

This study synthesized later first-row transition metal complexes of hydroxyacetone derived N4-methyl substituted thiosemicarbazone, and determined their crystal structures and spectroscopic characterization. The complexes showed different molecular structures and crystalline structures. The synthesized compounds exhibited high activity in in vitro antitubercular tests.
The present work reports the syntheses, crystal structures and spectroscopic characterization of later first-row transition metal complexes of hydroxyacetone derived N4-methyl substituted thiosemicarbazone. The molecular structures of Co(II) and Ni(II) complexes are determined by single crystal X-ray diffraction method. The crystal structures reveal that the Co(II) and Ni(II) complexes have crystallized in monoclinic and triclinic crystal systems with C2/c and P-1 space groups, respectively. The ligand, 1-(1-hydroxypropan-2-ylidene)-N4-methylthiosemicarbazone ligates in a neutral, SNO tridentate fashion to the central metal ions. The numerous physicochemical investigations carried out to the synthesized complexes disclose the metal to ligand stoichiometry to be 1:2 in Co(II), Ni(II) and Zn(II) complexes whereas 1:1 in Cu(II) complex. The ligand environment forms a distorted octahedral geometry around Co(II), Ni(II) and Zn(II) metal centers, while square pyramidal geometry over Cu(II) ion. The in vitro antitubercular results against Mycobacterium tuberculosis affirm that the synthesized compounds are four-fold more active than the standard drug, Streptomycin and two-fold more active than the other two standards used, Pyrazinamide and Ciprofloxacin. (C) 2020 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available